Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Hanna L. Hägglund, Agneta Månsson Broberg, Sandra Eloranta, Elham Hedayati, Christel Hedman
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
10.1093/eurheartj/ehac244 · 2022
Cardio-oncology services: rationale, organization, and implementation
10.1093/eurheartj/ehy453 · 2019
Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study
10.1200/jco.2015.64.0409 · 2016
A population-based study of cardiovascular disease mortality risk in US cancer patients
10.1093/eurheartj/ehz766 · 2019
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
10.1093/eurheartj/ehab674 · 2022
Shared risk factors in cardiovascular disease and cancer
10.1161/circulationaha.115.020406 · 2016
The spectrum of epidemiology underlying sudden cardiac death
10.1161/circresaha.116.304521 · 2015
Out-of-hospital cardiac arrest: current concepts
10.1016/s0140-6736(18)30472-0 · 2018
Poorer survival after out-of-hospital cardiac arrest among cancer patients: a population-based register study
2023
Cancer is not associated with higher short or long-term mortality after successful resuscitation from out-of-hospital cardiac arrest when adjusting for prognostic factors
2020
Long-term survival of out-of-hospital cardiac arrest patients with malignancy
10.1016/j.ajem.2017.04.051 · 2017
Comorbidity and survival in out-of-hospital cardiac arrest
10.1016/j.resuscitation.2018.10.006 · 2018
Unresolved referenced work
2023
Unresolved referenced work
2024
Unresolved referenced work
2025
Registers of the Swedish total population and their use in medical research
10.1007/s10654-016-0117-y · 2016
Unresolved referenced work
2025
Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register
10.1007/s10654-025-01221-0 · 2025
Unresolved referenced work
2021
The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research
10.1007/s10654-019-00511-8 · 2019
The Swedish cause of death register
10.1007/s10654-017-0316-1 · 2017
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
10.1007/s10654-009-9350-y · 2009
Directed acyclic graphs for clinical research: a tutorial
10.7602/jmis.2023.26.3.97 · 2023
Adaptation of the charlson comorbidity index for register-based research in Sweden
10.2147/clep.s282475 · 2021
Unresolved referenced work
2024
Earnings and work loss after colon and rectal cancer: a Swedish nationwide matched cohort study
10.1016/j.eclinm.2024.102770 · 2024
Unresolved referenced work
2023
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007
Cardiovascular disease burden in adult patients with cancer: an 11-year nationwide population-based cohort study
10.1016/j.ijcard.2020.04.080 · 2020
Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients
2016
Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis
10.1016/j.jaccao.2022.03.004 · 2022
How common is pre-existing cardiovascular disease in cancer patients: what do we know? Does it matter?
10.1016/j.jaccao.2022.05.001 · 2022
Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study
10.1182/blood.2024025362 · 2024
Trousseau's syndrome: multiple definitions and multiple mechanisms
10.1182/blood-2006-10-053736 · 2007
Epidemiology of cancer-related venous thromboembolism
10.1016/j.beha.2008.12.001 · 2009
Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry
10.1136/heartjnl-2024-324137 · 2024
Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden
10.1016/j.ejca.2011.09.015 · 2012
Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) study
10.1016/j.jacc.2022.04.042 · 2022
Incident cardiovascular disease among adults with cancer: a population-based cohort study
10.1016/j.jaccao.2022.01.100 · 2022
Out-of-hospital cardiac arrest event after cancer diagnosis: a Korean metropolitan cohort study
10.1186/s12885-025-13717-9 · 2025
Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: cardiooncology state-of-the-art review
10.1016/j.jaccao.2025.07.001 · doi-reference
Cardiovascular events and venous thromboembolism after primary malignant or non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom)
10.1186/s12916-023-03153-6 · doi-reference
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
10.1038/s41416-019-0510-x · doi-reference
Correlation between pancreatic cancer and metabolic syndrome: a systematic review and meta-analysis
10.3389/fendo.2023.1116582 · doi-reference
Risk factors and prevention of cancer and CVDs: a chicken and egg situation
10.3390/jcm14093083 · doi-reference
Cardiovascular complications associated with contemporary lung cancer treatments
10.1007/s11864-021-00869-6 · doi-reference
Lung cancer as a cardiotoxic state: a review
10.1007/s12032-017-1012-4 · doi-reference
Lung cancer and cardiovascular disease: common pathophysiology and treatment-emergent toxicity
10.1016/j.jaccao.2025.05.003 · doi-reference
Cardiovascular disease after hematopoietic stem cell transplantation in adults: JACC: cardiooncology state-of-the-art review
10.1016/j.jaccao.2024.06.004 · doi-reference
Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy
10.1161/circulationaha.114.013777 · doi-reference
Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology state-of-the-art review
10.1016/j.jaccao.2024.07.016 · doi-reference
Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies
10.1038/s41408-023-00849-z · doi-reference
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
10.1016/j.lungcan.2025.108629 · doi-reference
Fatal heart disease among cancer patients
10.1038/s41467-020-15639-5 · doi-reference